II. Epidemiology
- Incidence in Alzheimer's Disease: 50%
III. Symptoms: Positive
-
Hallucinations
- Visual (most common)
- Phantom Border Syndrome
- Unseen person living in home
-
Delusions
- Patient believes items are being stolen
- Patient believes they must go to work
- Capgras' Syndrome
- Patient suspects care givers are imposters
- Thought disorders
- Incoherent
- Tangentiality
- Disorganized behavior
IV. Symptoms: Negative
- Anhedonia
- Flat affect
- Apathy
- Social withdrawal
V. Differential Diagnosis
- Schizophrenia
- Primary Mood Disorder (Major Depression)
- Substance Abuse, Intoxication or withdrawal
- Delirium
- Parkinson's Disease
- Dementia
- Intracranial lesion
- Cerebrovascular Accident
- Subdural Hematoma
VI. Management: General
- Indications for management
- Psychosis Causes fear or unwanted behavior
- Psychosis less commonly causes Agitation, aggression
- Behavioral Techniques
- Distraction
- Reorient with familiar objects, verbal cues, calendar
- Redirection
- Gentle face-saving confrontation
- Maintain sleep-wake cycle
VII. Management: Medications (Neuroleptics)
-
General
- Indicated for failed behavioral techniques
- Start with low dose but high potency agents
- Give medications on scheduled dosing (Not prn)
- Efficacy
- Patient will still experience psychotic symptoms
- Medication goal is to reduce associated behaviors
- Fear
- Agitation
- Attempt Medication Withdrawal after 3 months
- Precautions
- No Antipsychotics are FDA approved for Dementia
- Atypical Antipsychotics increase mortality risk
- FDA issued a black-box warning on Antipsychotics
- Associated with increased Cardiovascular Risk
-
Neuroleptic Preparations
- Typical Antipsychotics (Extrapyramidal Side Effects)
- Haloperidol (Haldol) 0.5-3.0 mg qd
- Thiothixene (Navane) 1.0-6.0 mg qd
- Thioridazine (Mellaril)
- Atypical Antipsychotics (less adverse effects)
- Exacerbate Parkinson's Disease movement
- Risperidone (Risperdal) 0.25 - 3.0 mg qd
- Avoid Olanzapine
- Not recommended in the elderly
- Higher risk of CVA and overall mortality
- Do not exacerbate Parkinson's Disease
- Quetiapine (Seroquel) 12.5 - 200 mg qd
- Clozapine 6.5 - 75 mg qd
- Exacerbate Parkinson's Disease movement
- Typical Antipsychotics (Extrapyramidal Side Effects)
- Adverse Effects: Extrapyramidal
- Akathisia (motor restlessness)
- Akinesia
- Pseudo-Parkinson's Symptoms
- Avoid Cogentin or Artane
- Associated Anticholinergic effects
- Decreased cognitive function
- Dry Mouth
- Urinary Retention
- Adverse effects: Other
- Hyperglycemia (screen Blood Sugar every 6 months)